Literature DB >> 5494500

[Autoimmune diseases].

H Begemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5494500

Source DB:  PubMed          Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd        ISSN： 0003-9195


× No keyword cloud information.
  16 in total

Review 1.  [PATHOGENESIS OF CHRONIC HEPATITIS AS AN IMMUNOLOGICAL PROBLEM].

Authors:  F SCHEIFFARTH; H WARNATZ
Journal:  Klin Wochenschr       Date:  1965-05-01

2.  Auto-immunity and aging.

Authors:  R L WALFORD
Journal:  J Gerontol       Date:  1962-07

3.  Anti-gamma globulin factors in liver disease.

Authors:  L BONOMO; J LOSPALLUTO; M ZIFF
Journal:  Arthritis Rheum       Date:  1963-04

4.  [Role of the properdin system in the normal and stimulated blood cell structure].

Authors:  H FISCHER; W FRITZSCHE; H ARGENTON
Journal:  Klin Wochenschr       Date:  1958-05-01

5.  [Autoimmunization as a pathogenetic principle].

Authors:  F Scheiffarth; H Warnatz
Journal:  Internist (Berl)       Date:  1970-01       Impact factor: 0.743

Review 6.  [Immunologic phenomena in liver diseases: significance of mitochondrial antibodies].

Authors:  P A Berg; D Doniach; I M Roitt
Journal:  Klin Wochenschr       Date:  1969-12-15

7.  The release of thyroglobulin from the thyroid gland into thyroid lymphatics; the identification of thyroglobulin in the thyroid lymph and in the blood of monkeys by physical and immunological methods and its estimation by radioimmunoassay.

Authors:  P M Daniel; O E Pratt; I M Roitt; G Torrigiani
Journal:  Immunology       Date:  1967-05       Impact factor: 7.397

8.  [Autoimmunization and autoaggression].

Authors:  C Steffen
Journal:  Med Welt       Date:  1970-04-18

9.  [Immunologic aspects of aging].

Authors:  R L Walford
Journal:  Klin Wochenschr       Date:  1969-06-01

10.  X-radiation and alkylating agents as possible "trigger" mechanisms in the autoimmune complications of malignant lymphophroliferative disease.

Authors:  F B Lewis; R S Schwartz; W Dameshek
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.